Naropin Injection, Solution
Product Images NDC 63323-287

Product Visual Gallery

This gallery contains 44 technical images submitted to the FDA as part of the official labeling for Naropin (NDC 63323-287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nar01 0005 01

This appears to be a chemical formula for a compound with molecular weight of 328.89. It contains the elements carbon, hydrogen, nitrogen, and chlorine. The compound may have some applications in the field of chemistry.*

FDA Label Image

Nar01 0005 02

FDA Label Image

Nar01 0005 03

Naropin is an injection used for infiltration, nerve block, and epidural administration only. It should not be administered intravenously. It comes in a 10 mL single dose vial with a concentration of 20 mg per 10 mL. Naropin is a trademark of Fresenius Kabi USA, LLC. The vial should be stored between 20° and 25°C (68° to 77°F). The NDC number for Naropin is 63323-285-03 and the lot/exp number is 402721D.*

FDA Label Image

Nar01 0005 04

FDA Label Image

Nar01 0005 05

Naropin is a medication that comes in a 20 mL single dose vial, with a strength of 0.40 mg per 20 mL injection. It is intended for infiltration, nerve block, and epidural administration only and should not be administered intravenously. Naropin is a trademark of Fresenius Kabi USA, LLC and should be stored at 20° to 25°C (68° to 77°F) as per USP Controlled Room Temperature guidelines. The product has an NDC code of 63323-285-07 and lot/exp 402722D.*

FDA Label Image

Nar01 0005 06

Naropin (ropivacaine HCI Injection, USP) is a medication used for infiltration, nerve block, and epidural administration purposes only. It is not meant for intravenous administration. The medication comes in 20 mL single-dose vials containing 2 mg per ml of Ropivacaine HCI. The solution has no preservatives and should be discarded if unused. The package retains instructions for autoclaving, storage, and dosage. Users should not use the solution if it is discolored or contains a precipitate. The container closure does not contain natural rubber latex, and the medication is a trademark of Fresenius Kabi USA, LLC.*

FDA Label Image

Nar01 0005 07

Naropin (ropivacaine HCl Injection, USP) is a medication used for infiltration, nerve block, and epidural administration. It comes in a 20 ML single-dose vial with a 50/100 mg per 20 mL concentration. It is important to note that this medication is not for intravenous administration. The medication is stored at 20° to 25°C (68° to 77°F) and bears the trademark of Fresenius Kabi USA, LLC. The NDC code for this medication is 63323-286-05, and the lot/expression number is not available.*

FDA Label Image

Nar01 0005 08

Naropin is a ropivacaine HCI injection solution with a concentration of 5 mg per mL. It is intended for use in nerve block, infiltration, and epidural administration only, and not for intravenous administration. It comes in 20mL single dose vials without preservatives. The solution may be autoclaved, and the full prescribing information can be found in the package insert. It should be stored at 20°C to 25°C (68°F to 77°F) and the container closure is free from natural rubber latex. Naropin is a trademark of Fresenius Kabi USA, LLC.*

FDA Label Image

Nar01 0005 09

Naropin’ is a brand of ropivacaine HCI injection used for infiltration, nerve block, and epidural administration. It cannot be given intravenously and comes in a 30mL single-dose vial. It should be stored at 20°C to 25°C and is a trademark of Fresenius Kabi USA, LLC. The provided NDC number is 63323-286-09, and the lot number is 402631D with an expiration date.*

FDA Label Image

Nar01 0005 10

FDA Label Image

Nar01 0005 11

Naropin is a ropivacaine HCl injection, USP used for infiltration, nerve block, and epidural administration only. It comes in a single-dose vial of 30mL with a dosage of 150mg per vial. It is not intended for intravenous use and should be stored at a temperature range of 20°C to 25°C. The manufacturer of this injection is Fresenius Kabi USA, LLC.*

FDA Label Image

Nar01 0005 12

FDA Label Image

Nar01 0005 13

Naropin is a medicine that comes in a 20 mL single dose vial containing 750/150 mg per 20 mL of ropivacaine HCl injection, for nerve block and epidural administration only. The medicine should not be administered intravenously, and it is only available with a prescription. Naropin is a trademark of Fresenius Kabi USA, LLC, and it should be stored at 20° to 25°C (68°to 77°F) [see USP Controlled Room Temperature]. The NDC code for this medication is 63323-287-03, and batch number or expiration date is 402792D.*

FDA Label Image

Nar01 0005 14

Naropin is a USP injection used for nerve block and epidural administration that is not recommended for intravenous administration. It comes in a 20mL single-dose vial with 7.5mg per mL of Ropivacaine HCI, sodium chloride, and sodium hydroxide and/or hydrochloric acid to adjust pH. It has no preservatives and should be discarded if unused. The solution can be autoclaved and should not be used if discolored or contains a precipitate. The container closure is free of natural rubber latex. The trademark of Naropin is owned by Fresenius Kabi USA, LLC, and it should be stored at 20° to 25°C. The package insert should be consulted for complete prescribing information and dosage.*

FDA Label Image

Nar01 0005 15

This is a description of a drug called NAROPIN. It is a Ropivacaine HCI injection for epidural administration only. The drug comes in a 10 mL single-dose vial with 100 mg per 10mL concentration. It is not meant for intravenous administration. The drug is trademarked by Fresenius Kabi USA, LLC, and should be stored at 20°C to 25°C. The product's lot number and expiration date are 63323-288-03 and 402790D, respectively.*

FDA Label Image

Nar01 0005 16

Naropin is an injection medication containing Ropivacaine HCI with 100mg per 10mL concentration. It is supplied in 10 mL single-dose vials with 25 vials per pack. The medication is for prescription use only and contains no preservatives. The pH is adjusted with sodium hydroxide and/or hydrochloric acid. The solution may be autoclaved and should be discarded if discolored or contains a precipitate. The product must be stored at 68-77°F (20°–25°C). The container closure is free from natural rubber latex. For complete prescribing information, refer to the package insert.*

FDA Label Image

Nar01 0005 17

Naropin is an injection medication containing ropivacaine HCI intended specifically for epidural administration. It should not be administered intravenously. The medication is available in 20 ML single dose vials, with each vial containing 200 mg per 20 mL, equating to 10 mg per mL. It is important to store the medication between 20° to 25°C (68° to 77°F), and the medication should be used before the expiration date as printed on the packaging. This medication is produced by Fresenius Kabi USA, LLC, and has a trademark within the medical sphere.*

FDA Label Image

Nar01 0005 18

NDC 63323-288-21 is a Naropin medication used for injections. It contains Ropivacaine HCI in Sodium Chloride solution. It is available in a 20 mL single-dose vial, and each mL comprises 10 mg of Ropivacaine HCI, 7.1 mg of Sodium Chloride, and Hydrochloric acid or Sodium Hydroxide for pH adjustment. This medication is free of preservatives and is guaranteed as a single-dose container. It is essential to read the package insert for comprehensive prescription information and consult a professional before usage. The Naropin container closure is not made with natural rubber latex. The manufacturer is Fresenius Kabi USA, LLC. Store in USP controlled room temperature of 20° to 25°C (68° to 77°F) and avoid using if the solution is discolored or contains a precipitate.*

FDA Label Image

Nar01 0005 19

FDA Label Image

Nar01 0005 20

This is a description of a medication with the active ingredient Ropivac. Each mL of the medication contains 2 mg of Ropivac and sodium chloride. The medication does not contain preservatives and should not be used if the solution is discolored or contains a precipitate. The container closure does not contain natural rubber latex. It should be stored between 20°C to 25°C. For dosage and prescribing information, consult the package insert. The source is a website for Fresenius Kabi, located in Lake Zurich, Illinois.*

FDA Label Image

Nar01 0005 21

This appears to be a product label for Ropivac Chloride, with instructions to adjust pH to 4.0 using acid. It contains no preservatives and dosage instructions and prescribing information are available in the package insert. The product should not be used if the solution is discolored or has a precipitate. Storage instructions indicate that it should be kept between 20°C to 25°C (68°F to 77°F). There is also contact information on the label for Fresenius Kabi, the manufacturer.*

FDA Label Image

Nar01 0005 22

This is a description of a medical solution contained in a 1000 mg per 200 mL bottle with 5 mg per mL concentration. It contains Ropivacaine HCI, sodium chloride, and hydrochloric acid to adjust pH. The medication does not include preservatives and instructions for dosages can be found on the package insert. The solution should not be used if discolored or containing a precipitate. The temperature for storage is between 20°C to 25°C. The container closure is free of natural rubber latex. The text also mentions a lot number of 402571D and an expiration date.*

FDA Label Image

Nar01 0005 23

This is a pharmaceutical label for Naropin, which is an injection containing ropivacaine HCl. It is for Rxonly and supplied in 10 mL ampules with a concentration of 20mg per 10mL. It is not intended for inhalation. It is manufactured for Fresenius Kabi and made in Norway.*

FDA Label Image

Nar01 0005 24

This is a description of a medication called Ropivacaine HCl Injection, USP, which is delivered in a pre-sterilized 10mL plastic ampule. The enclosed plastic ampule is sterile and should not be used if it is discolored or contains a precipitate. This medication is used for Nerve Block and Epidural Administration Only, and is not for Intravenous Administration or Inhalation. The concentration of this medication is 20mg per 10mL (2mg per mL). The package insert should be referred to for the full prescribing information and dosage. This medication should be stored at a temperature between 20° to 25°C (68° to 77°F) and should be used as directed by a healthcare professional. The NDC code for this medication is 63323-285-01-278510.*

FDA Label Image

Nar01 0005 25

This is a description of a drug called "Naropm". It is a type of injection containing ropivacaine HCI and used for infiltration, nerve block, and epidural administration. It is not recommended for intravenous or inhalation administration. The package is sterile and contains five presterilized plastic ampules each containing 20mg per 10mL of the drug. This drug is only available with a prescription (Rx only).*

FDA Label Image

Nar01 0005 26

This is a description of a medication called Naropin, which has the NDC code 63323-285-06 and comes in a 20 mL ampule containing 40 mg of ropivacaine HCl Injection USP with a concentration of 2 mg per mL. The medication is not for inhalation and is only available with a prescription. The medication is manufactured by Fresenius Kabi in Norway and the container has the number 402355E on it. The lot number is FUA 0942 01-63-14-039D. The rest of the text is not readable.*

FDA Label Image

Nar01 0005 27

Narop’n (ropivacaine HCl Injection, USP) is a sterile solution in a presterilized plastic ampule containing 40 mg of ropivacaine HCl per 20 mL. It is intended for infiltration, nerve block, and epidural administration only. The enclosed plastic ampule is sterile, and if the unopened package is undamaged. The stored temperature range is 20°C to 25°C (68°F to 77°F). Do not use if the solution is discolored or a precipitate is present. Check the package insert for complete prescribed information. Not for intravenous administration or inhalation, for Rx only. The NDC code is 63323-285-06, and the FUA code is 0942 01-73-14-002F 44844F.*

FDA Label Image

Nar01 0005 28

This seems to be a product description of Naropin injectable solution containing Ropivacaine HCI for nerve block, infiltration, and epidural administration. It comes in pre-sterilized 20mL plastic ampoule units and should not be used for intravenous administration or inhalation. The pH of the solution is adjusted to 4.0 to 6.0 with sodium hydroxide and/or hydrochloric acid. It should be stored at 20 to 25°C in a USP controlled room temperature and should not be used if it appears discolored or contains a precipitate. Patients should consult the package insert for dosage and prescribing information.*

FDA Label Image

Nar01 0005 29

This text is a label of Naropin® which is an injection medication containing ropivacaine HCl. It warns to not inhale and should be used only as directed by a doctor or healthcare professional. The manufacturer is Fresenius Kabi, located in Lake Zurich, IL. The medication is made in Norway and the label includes the National Drug Code (NDC) number and a unique serial number.*

FDA Label Image

Nar01 0005 30

The text is a description of a medication called Ropivacaine HCl Injection, USP, contained in a presterilized plastic ampule of 20mL with a concentration of 7.5mg per mL, used for nerve block and epidural administration only. It warns not to use if the solution is discolored or has a precipitate and indicates storage conditions at 20° to 25°C. The NDC code 63323-287-01 and Rx only mention are also provided.*

FDA Label Image

Nar01 0005 31

This is a description for a drug called Naropin'. It comes in an enclosed plastic ampule unit which is sterile. The drug is administered for nerve block and epidural only and should not be used for intravenous administration or inhalation. The drug contains 150mg per 20mL or 75mg per mL. The storage temperature of the drug should be between 20 to 26 degree Celsius. The drug is not available for sale without a prescription.*

FDA Label Image

Nar01 0005 32

This is a description of Naropin® (ropivacaine HCl Injection, USP), a medication used for local anesthesia. The package includes an ampule with a concentration of 0.5%, containing either 50, 100mg per 20mL or 5mg per mL. The medication is not intended for inhalation and should only be used with a prescription. The manufacturer is Fresenius Kabi, located in Lake Zurich, IL, USA. The ampule is made in Norway with an identification number FUA 0952 01-63-14-040D.*

FDA Label Image

Nar01 0005 33

This is a drug called Naro 'n® consisting of 20 mL Plastic Ampule containing ropivacaine HCl Injection, USP. The Enclosed plastic ampule is sterile when unopened, undamaged package. It has 100 mg per 20 mL (5 mg per mL). The package insert should be consulted for full prescribing and dosage information. This drug is not suitable for inhalation and should be stored at 20° to 25°C (68° to 77°F) as per the USP Controlled Room Temperature instructions. The solution should not be used if it is discolored or contains a precipitate. The product is Rx only, and the manufacturer is Fresenius Kabi. The drug has a NDC code of 63323-286-0 and the packaging comes with a unique code (01)00363323286019. The drug has been made in Norway.*

FDA Label Image

Nar01 0005 34

Naropin is a medication from Fresenius Kabi USA, LLC. It comes in plastic ampule units and contains 100mg per 20mL. The medication is meant for infiltration, nerve block, and epidural administration only; it is not for intravenous administration or inhalation. The storage temperature recommended is at 20°C to 25°C (68°F-77°F). The text also includes various identification codes and marks.*

FDA Label Image

Nar01 0005 35

Naropin® is a medication with the active ingredient ropivacaine HCl that comes in an ampule for injection with a concentration of 10mg per mL, packaged by Fresenius Kabi in Lake Zurich, Illinois. It is not to be inhaled and is only available with a prescription. The ampule's National Drug Code number is 63323-288-01, and it has the lot number 278810. The medication is made in Norway.*

FDA Label Image

Nar01 0005 36

This is a description of a medicine container that contains 10 mL plastic ampule of ropivacaine HCL injection USP: a 100mg per 10 mL, 10mg per mL solution. The enclosed plastic ampule is sterile before opening. It provides dosage and full prescribing information. This medication is for epidural administration only, and not for intravenous administration or inhalation. The solution should not be used if discolored or contains a precipitate. The solution should be stored at 20°C to 25°C. The manufacturer is Fresenius Kabi and the location of the product's manufacturing is Norway.*

FDA Label Image

Nar01 0005 37

FDA Label Image

Nar01 0005 38

Naropin® is a medication administered through injection with 10mg per mL, and the entire ampule contains 200mg. It is not meant for inhalation and is distributed by Fresenius Kabi from Lake Zurich. The product is manufactured in Norway.*

FDA Label Image

Nar01 0005 39

Narop 'n® is a presterilized 20 mL plastic ampule containing ropivacaine HCl injection, USP. It is intended for epidural administration only and is not for intravenous administration or inhalation. Each ampule contains 200 mg per 20 mL (10 mg per mL) and is to be used following the directions provided in the package insert. The enclosed plastic ampule is sterile as long as the package is unopened and undamaged. It should be stored at 20° to 25°C (68° to 77°F) and should not be used if the solution is discolored or contains a precipitate. The product is manufactured for Fresenius Kabi in Norway and is marked with the NDC 63323-288-06 and the lot number FUA 0982 01-73-14-006F 44847F.*

FDA Label Image

Nar01 0005 40

This is a description for a medication called "Naropin". It is an injection containing ropivacaine HCI and comes in packages of 20mL. It is intended for epidural administration and is not to be used intravenously or inhaled. The package contains 5 presterilized 20mL plastic ampule units, and the medication is only available by prescription.*

FDA Label Image

Nar01 0005 41

Naropin® s is a sterile solution of ropivacaine HCI Injection, USP, used for infiltration and epidural administration only. It contains 2mg of Ropivacaine HCI per mL with no preservatives and sodium chloride at 8.6 mg/mL. Sodium hydroxide and/or hydrochloric acid are also included to adjust pH to 4.0 to 6.0. The solution is single dose only, and the unused portion should be discarded. The usual dosage is advised as per the package insert. The solution is to be used immediately after opening and must be stored at 20° to 25°C (68° to 77°F) with controlled room temperature. The above details are for pharmaceutical use only, and it is RX only.*

FDA Label Image

Nar01 0005 42

This is a description of a product labeled as Product No. 278561 with the volume of 100mL x 24 manufactured for Naropin Y Ropoes and Y N KABI. It is recommended to store the product at 20° to 25°C. The product contains ropivacaine HCl Injection, USP with a concentration of 200mg/100mL (2mg/mL) and is available only on prescription. The product has an NDC code of 63323-285-61 and is made in Norway. The label shows the product's expiration date (MM-DD-YYYY), lot number (0000000), and quantity (24). Instructions for control room temperature are also given, and the manufacturer's website is provided www.fresenius-kabi.com/us.*

FDA Label Image

Nar01 0005 43

Naropin is a medicated injection used for Infiltration and Epidural administration because it contains Ropivacaine HCl USP. It comes in a 200mL container, and a 2mg per 1mL formula is used. The pH ranges from 4.0 to 6.0 and does not contain any preservatives. It is advised to utilize the contents immediately after opening, as this injection is not supposed to be consumed as a multi-dose. The product should be stored at a controlled room temperature, under 20° to 25°C (68° to 77°F). Furthermore, the container is not made up of natural rubber latex or polyvinyl chloride, and it is manufactured in Norway by Mid. For: Lor' \'] FRESENIUS KABI EXP Lake Zurich, IL 60047 1. Please refer to the package label for the recommended dose usage.*

FDA Label Image

Nar01 0005 44

Product No. 278563 is N aropin’ IR, a Ropivacaine HCI Injection used for pain relief. This injection comes in a 400mg/200mL (2mg/mL) controlled room temperature solution. The package comes with 24 units, with one unit containing 200 mL of the solution. The manufacturing company is Fresenius Kabi USA, LLC and the product is made in Norway. The NDC number is 63323-285-63 and the expiration date and lot number are printed on the package. The provided text also contains some unreadable characters.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.